Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …
CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …
